List view / Grid view
27 July 2018 | By Bruker
Two webinar sessions will be available on 27 September at 9AM (BST) and 4PM (BST). Select your preferred time slot during registration. The webinar will describe how 2D NMR can offer protein biochemists unprecedented analytical precision. By assigning just one spectrum, users can obtain a unique fingerprint of a protein at…
19 July 2018 | By Mike Stones
The EU and Japan have agreed to widen the range of medicines for which they will recognise each other’s inspections of manufacturing sites.
12 June 2018 | By European Pharmaceutical Review
Shape-conforming hydrogel leverages the body's own healing mechanisms rather than releasing drugs or biologics...
5 June 2018 | By European Pharmaceutical Review
The U.S. Food and Drug Administration has approved Fulphila (pegfilgrastim-jmdb) as the first biosimilar to Neulasta to help reduce the risk of infection during cancer treatment.
23 May 2018 | By European Pharmaceutical Review
Researchers have developed a highly specific apoptosis assay designed for immunofluorescence microscopy analysis of fixed core needle biopsy specimens...
13 April 2018 | By European Pharmaceutical Review
In this In-Depth Focus; early biotherapeutic lead optimisation for more efficient drug discovery and development, and turning promising compounds into drug candidates.
1 March 2018 | By Dr Payam Behzadi
In parallel with the use of a wide range of antibiotics for treating infectious diseases worldwide, antimicrobial resistance has significantly increased. For this reason, the application of an advanced pangenomic technique like DNA microarray can be an effective, rapid, accurate, sensitive, specific and flexible methodology for detecting, identifying and determining…
5 February 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Researchers have systematically analysed and quantified the interactions of all proteins with metabolites on the level of the whole proteome...
4 January 2018 | By Johan Devenyns, Johan Devenyns - PharmaFluidics
Much rests on the further development of bioanalytical technologies which allow the highest level of sensitivity on small samples, and robust, high reproducibility across large populations. Johan Devenyns, CEO PharmaFluidics, explains further...
15 December 2017 | By David Keller
Designing appropriate non-clinical safety studies requires thoughtful, and sometimes experimental, consideration of the delivery methodology for the therapeutic. The choice of formulation affects drug release and absorption and has a direct impact on the pharmacokinetic profile and associated response of the model system. The formulation should be compatible with the…
8 December 2017 | By European Pharmaceutical Review
A team of researchers set out to discover the disease pathways of a rare genetic kidney disease and consequently found a compound that stops the disease in its tracks.
29 November 2017 | By Abbvie Contract Manufacturing
State-of-the-art contract manufacturing...
29 November 2017 | By FUJIFILM Diosynth Biotechnologies
Technical leadership in contract development and manufacturing...
21 November 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
Boehringer Ingelheim has announced the launch of a new platform offering free and open access to selected pre-clinical molecules for a non-clinical investigation to scientists worldwide...
15 November 2017 | By Quotient Sciences
Quotient Clinical, the drug development services organisation, announces its renaming to Quotient Sciences (Quotient), following the acquisitions of Co-Formulate, QS Pharma and SeaView Research...
Send this to a friend
Follow: